Levosimendan: current data, clinical use and future development

Levosimendan is an inodilator indicated for the short-term treatment of acutely decompensated severe chronic heart failure, and in situations where conventional therapy is not considered adequate. The principal pharmacological effects of levosimendan are (a) increased cardiac contractility by calciu...

Descripción completa

Detalles Bibliográficos
Autores principales: Nieminen, M S, Fruhwald, S, Heunks, L M A, Suominen, P K, Gordon, A C, Kivikko, M, Pollesello, P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: EDIMES Edizioni Internazionali Srl 2013
Materias:
Review-Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868185/
https://www.ncbi.nlm.nih.gov/pubmed/24364017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3868185/
https://www.ncbi.nlm.nih.gov/pubmed/24364017

Ejemplares similares